Neoadjuvant chemotherapy: Does it have benefits for the surgeon in the treatment of advanced squamous cell cancer of the oral cavity?

Pathology and Oncology Research

Volumn 16, Issue 2, 2010, Pages 207-212

  Olasz, Lajos ^a   Szalma, József ^a   Orsi, Eniko ^a   Tornóczky, Tamás ^a   Markó, Tamás ^a   Nyárády, Zoltán ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Neoadjuvant chemotherapy. Surgical margin; Oral cancer; OSCC; Primary tumor regression

Indexed keywords

BLEOMYCIN; CISPLATIN; FOLINATE CALCIUM; METHOTREXATE; MITOLACTOL; VINCRISTINE;

ADULT; ALOPECIA; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER TISSUE; CLINICAL PROTOCOL; CONTROLLED STUDY; DERMATITIS; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; GASTRITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; PREOPERATIVE TREATMENT; SQUAMOUS CELL CARCINOMA; SURGEON; TREATMENT INDICATION; WOUND HEALING IMPAIRMENT;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; MITOLACTOL; MOUTH NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORAL SURGICAL PROCEDURES; PHYSICIANS; SURGERY, ORAL; VINCRISTINE;

EID: 77955686670     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-009-9208-3     Document Type: Article

References (46)

1. Gaudi I, Kásler M (2002) The course of cancer mortality in Hungary between 1975-2001 (English abstract). Magy Onkol 46:291-295
2. Zs N, Velich N, Bogdán S et al (2005) The prognostic role of clinical, morphological and molecular markers in oral squamosus cell tumors. Neoplasma 52:95-101
3. Taylor SG (1997) Head and neck cancer. Cancer Chemot Biol Response Mod Ann 17 Elsev Science
4. Gibson MK, Forastiere AA (2004) Multidisciplinary approaches in the management of advanced head and neck tumors: state of art. Curr Opin Oncol 16:220-224
5. Forastiere AA (2004) Is there a new role for induction chemotherapy in the treatment of head and neck cancer? J Natl Cancer Inst 96:1647-1649
6. Gibson MK, Forestiere AA (2006) Reassassment of the role of induction chemotherapy for head and neck cancer. Lancet Oncol 7:565-574
7. Bryne M, Koppang HS, Lilleng R et al (1992) Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 166:375-381
8. Spiro RH, Guillamondegui O, Paulin AF et al (1999) Pattern of invasion and margin assessment in patients with oral tongue cancer. Head Neck 21:408-413
9. Cooper JS, Pajak TF, Forastiere AA et al (2004) Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937-1944
10. Loree TR, Strong EW (1990) Significance of positive margins in oral cavity squamous carcinoma. Am J Surg 160:410-414
11. Sutton DN, Brown JS, Rogers SN et al (2003) The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 32:30-34
12. Beitler JJ, Smith RV, Silver CE et al (1998) Close or positive margins after surgical resection for the head and neck cancer patient: the addition of brachytherapy improves local control. Int J Radial Oncol Biol Phys 40:313-317
13. Jacobs JR, Ahmad K, Casiano R et al (1993) Implications of positive surgical margins. Laryngoscope 103:64-68
14. Batsakis JG (1999) Surgical excision margins: a pathologist's perspective. Adv Anat Pathol 6:140-148
15. Woolgar JA, Rogers S, West CR et al (1999) Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncol 35:257-265
16. Licitra L, Grandi C, Guzzo M et al (2003) Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 21:327-333
17. Bettendorf O, Piffko J, Bankfalvi A (2004) Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy? Oral Oncol 40:110-119
18. Beckmann GK, Hoppe F, Pfreundner L et al (2005) Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer. Head Neck 27:36-43
19. van Es RJJ, van Nieuw-Amerongen N, Slootweg PJ et al (1996) Resection margin as a predictor or recurrence at the primary site for T1 and T2 oral cancers. Arch Otolaryngol Head Neck Surg 122:521-525
20. Perez CA, Marks J, Powers W (1977) Preoperative irradiation in head and neck cancer. Semin Oncol 4:387-397
21. Stevens KR, Moss WT (1975) Control of localised cancer. Combination of preoperative irradiation and surgery. JAMA 232:1158-1160
22. Carifi VG, Ohanion ML et al (1974) Results of high dose radiation and surgery in the treatment of advanced cancer of the head and neck. Am J Surg 128:580-582
23. Mohr C, Bohndorf W, Carstens J et al (1994) Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective multicentric randomised DÖSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow up). Int J Oral Maxillofac Surg 23:140-148
24. Volling P, Schroder M, Muller RP et al (1994) Induction chemotherapy in primary resectable head and neck tumors: a prospective randomized trial. Int J Oncol 4:909-914
25. Jakobs C, Makuch R (1999) Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the head and neck contracts program. J Clin Oncol 8:838-847
26. Maipang T, Maipang M, Geater A et al (1995) Combination chemotherapy as induction therapy for advanced resectable head and neck cancer. J Surg Oncol 59:80-85
27. Olasz L, Kwashie F, Herczegh P et al (1996) A comparative study of preoperative B-V-M-M chemotherapy and irradiation in advanced squamous cell cancer of the oral cavity. Neoplasma 43:51-56
28. Kovacs AF, Turowski B, Ghahremani MT et al (1999) Intraarterial chemotherapy as neoadjuvant treatment of oral cancer. J Craniomaxillofac Surg 27:302-307
29. AlSarraf M, Martz K, Herskovic A et al (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277-284
30. Benasso M, Lionetto R, Corvo R et al (2003) Impact of the treating institution on the survival of patients with head and neck cancer treated with concomitant alternating chemotherapy and radiation. Eur J Cancer 39:1895-1898
31. Hironaka S, Ohtsu A, Boku N et al (2003) Nonrandomised comparison between definitive chemoradiotherapy and radical surgery in patients with T 2-3 Nany Mo squamous cell carcinoma of the esophagus. Int J Rad Oncol Biol Phys 57:425-433
32. Psyrri A, Kwong M, DiStasio S et al (2004) Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: longterm follow-up. J Clin Oncol 22:3061-3069
33. Forastiere AA, Trotti A (1999) Radiotherapy and concurrent chemotherapy: a strategy that improves locoregional contro and survival in oropharyngeal cancer. J Natl Cancer Inst 91:2056-2066
34. Basu S, Khanra M, Dash B et al (1999) The role of neoadjuvant and adjuvant chemotherapy regimens consisting of different combinations of drugs in the treatment of advanced oral cancer. Med Oncol 16:199-203
35. Olasz L, Szabó I, Horvath A (1988) A combined treatment for advanced oral cavity cancers. Cancer 62:1267-1274
36. Price LA, Hill BT (1986) Impact of primary site Stage III and IV squamous cell carcinomas of the head and neck on 7-year survival figures following initial noncisplatin-containing combination chemotherapy. Resent Results Cancer Res 103:124-134
37. Athanasiadis J, Taylor S, Vokes EE et al (1997) Phase II. study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center. Rec Res Cancer 79:588-594
38. Grégoire V, Beauduin M, Humblet Y et al (1991) A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: report from the UCL-Oncology Group, Belgium. J Clin Oncol 9:1385-1392
39. Gibson MK, Li Y, Murphy B et al (2005) Eastern Cooperative Oncology Group. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol 23:3562-3567
40. Braun OM, Neumeister B, Neuhold N et al (1989) Histological grading of therapy induced regression in squamous cell carcinomas of the oral cavity. A morphological and immunohistochemical study. Path Res Pract 185:368-372
41. Sulfaro S, Frustaci S, Volpe R et al (1989) A pathologic assessment of residue and stromal changes after intra-arterial chemotherapy for head and neck carcinomas. Cancer 64:994-1001
42. Suba Z, Szabó G, Barabás J et al (1992) Histological evaluation of chemotherapeutically induced regression. Reg Cancer Treat 4:313-319
43. Olasz L, Németh Á, Nyárády Z et al (2004) Results and failures with or without cisplatin containing induction chemotherapy in the treatment of squamous cell carcinoma of the head and neck. Cancer Det Prev 28:65-71
44. Giralt JL, Gonzalez J, del Campo JM et al (2000) Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx. Cancer 89:939-945
45. Posner MR, Glisson B, Frenette G et al (2001) Multicenter phase I-II trial of docetaxel, cisplatin and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck. J Clin Oncol 19:1096-1104
46. Woolgar JA, Rogers SN, Lowe D et al (2003) Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread. Oral Oncol 39:130-137